Teva Canada Innovation et al. v. Apotex Inc. et al.
| Jurisdiction | Federal Jurisdiction (Canada) |
| Court | Federal Court (Canada) |
| Judge | Gleason, J. |
| Citation | 2014 FC 1070 |
| Date | 19 December 2014 |
| Subject Matter | STATUTES,EVIDENCE,ADMINISTRATIVE LAW,PRACTICE,PATENTS OF INVENTION |
Get this document and AI-powered insights with a free trial of vLex and Vincent AI
Get Started for FreeUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete access to the largest collection of common law case law on one platform
-
Generate AI case summaries that instantly highlight key legal issues
-
Advanced search capabilities with precise filtering and sorting options
-
Comprehensive legal content with documents across 100+ jurisdictions
-
Trusted by 2 million professionals including top global firms
-
Access AI-Powered Research with Vincent AI: Natural language queries with verified citations
Start Your 7-day Trial
19 practice notes
-
Eli Lilly Canada Inc. v. Apotex Inc. et al.
...SCC 66 , refd to. [para. 105]. Teva Canada Innovation et al. v. Apotex Inc. et al., [2015] F.T.R. TBEd. AP.034 ; 252 A.C.W.S.(3d) 322 ; 2014 FC 1070, dist. [para. AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. (2014), 457 F.T.R. 227 ; 244 A.C.W.S.(3d) 180 ; 2014 FC 638 , affd. (......
-
Gilead Sciences, Inc. v. Canada (Health)
...and refers to: AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 , per Rennie J, at para 321; Teva Canada Innovation v Apotex Inc, 2014 FC 1070, per Gleason J (as she then was), at paras 94-96; Takeda Canada Inc. v Canada (Health), 2015 FC 570 , per O’Reilly J, at paras 27, 29; Allergan In......
-
Allergan Inc. v. Apotex Inc. et al.
...of the parties: AstraZeneca Canada Inc v Apotex Inc , 2014 FC 638 [ Esomeprazole FC ] at para 321; Teva Canada Innovation v Apotex Inc , 2014 FC 1070 at paras 94-97; Takeda Canada Inc v Canada (Minister of Health) , 2015 FC 570 at paras 27-29. [14] Like Dr. Fix, Dr. Myrdal had prior kno......
-
Gemak Trust v. Jempak Corporation
... 2009 FC 676 at para. 66; Lundbeck Canada Inc. v. Canada (Health), 2009 FC 146 at para. 11; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 109; Apotex Inc. v. Shire LLC, 2017 FC 139 at para. 39; Amgen Canada Inc. v. Apotex Inc., 2015 FC 1261 at para. 15 (Amgen); Novarti......
Get Started for Free
14 cases
-
Eli Lilly Canada Inc. v. Apotex Inc. et al.
...SCC 66 , refd to. [para. 105]. Teva Canada Innovation et al. v. Apotex Inc. et al., [2015] F.T.R. TBEd. AP.034 ; 252 A.C.W.S.(3d) 322 ; 2014 FC 1070, dist. [para. AstraZeneca Canada Inc. et al. v. Apotex Inc. et al. (2014), 457 F.T.R. 227 ; 244 A.C.W.S.(3d) 180 ; 2014 FC 638 , affd. (......
-
Gilead Sciences, Inc. v. Canada (Health)
...and refers to: AstraZeneca Canada Inc v Apotex Inc, 2014 FC 638 , per Rennie J, at para 321; Teva Canada Innovation v Apotex Inc, 2014 FC 1070, per Gleason J (as she then was), at paras 94-96; Takeda Canada Inc. v Canada (Health), 2015 FC 570 , per O’Reilly J, at paras 27, 29; Allergan In......
-
Allergan Inc. v. Apotex Inc. et al.
...of the parties: AstraZeneca Canada Inc v Apotex Inc , 2014 FC 638 [ Esomeprazole FC ] at para 321; Teva Canada Innovation v Apotex Inc , 2014 FC 1070 at paras 94-97; Takeda Canada Inc v Canada (Minister of Health) , 2015 FC 570 at paras 27-29. [14] Like Dr. Fix, Dr. Myrdal had prior kno......
-
Gemak Trust v. Jempak Corporation
... 2009 FC 676 at para. 66; Lundbeck Canada Inc. v. Canada (Health), 2009 FC 146 at para. 11; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 109; Apotex Inc. v. Shire LLC, 2017 FC 139 at para. 39; Amgen Canada Inc. v. Apotex Inc., 2015 FC 1261 at para. 15 (Amgen); Novarti......
Get Started for Free
5 firm's commentaries
-
Pharma In Brief - Blinded Expert Evidence Favoured: Court Dismisses PM(NOC) Application For Ciclesonide
...has gained favour in other cases: AstraZeneca Canada Inc. v. Apotex Inc., 2014 FC 638 at para. 321; Teva Canada Innovation v. Apotex Inc., 2014 FC 1070 at para. 94." Link to decision: Takeda Canada Inc. and Takeda GMBH v The Minister of Health and Apotex Inc., 2015 FC 570 Norton Rose Fulbri......
-
Pharma In Brief - Generic v. Generic PM(NOC) Application Dismissed For Non-Infringement
...Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070 Drug: AZILECT® Nature of case: Section 6 prohibition proceedings under the PM(NOC) Regulations Successful party: Apotex Inc. Date of decision: December 19, 2014 (Public Judgment and Reasons); Novembe......
-
Whether To Blind Your Experts: The Answer Is Unclear
...decisions should certainly be taken into consideration at the time of contacting experts. Footnotes 1 Teva Canada Innovation v. Apotex, 2014 FC 1070 at para. 94-97 [hereinafter Teva 2 Ibid. at para. 94. 3 Ibid. at para. 96. 4 AstraZeneca Canada v. Apotex Inc., 2014 FC 638 at para. 321-324. ......
-
Formulation Patent Found Not To Be Infringed As A Redacted Excipient Was Not A 'Pentahydric Or Hexahydric Alcohol' (Intellectual Property Weekly Abstracts Bulletin (Week Of April 20, 2015)
...Excipient Was Not a "Pentahydric or Hexahydric Alcohol" Teva Canada Innovation and Teva Pharmaceutical Industries Ltd. v. Apotex Inc., 2014 FC 1070 Drug: rasagiline Apotex has successfully alleged that Teva's patent to "Stable Compositions Containing [Rasagiline]" will not be infringed by A......
Get Started for Free